In polarized epithelium direction of viral entry and release correlates with proclivity of a virus to establish local versus systemic infection. The Epstein-Barr virus (EBV), whose principal tissue reservoir is B lymphocytes, also has disease manifestations in epithelium, suggesting intertissue spread potentially influenced by epithelial cell polarity. We stably transfected the B lymphocyte EBV receptor (CR2/CD21) into Madin-Darby canine kidney (MDCK) epithelial cells used extensively to study effects of cell polarity on infection by both DNA and RNA viruses. CR2/CD21 was detected on both apical and basolateral surfaces of polarized MDCK cells, with predominant expression basolaterally. However, infectivity was up to four-fold greater apically, suggesting that endogenous cell surface molecules, sorted asymmetrically onto polarized plasma membranes, may be involved in EBV entry into MDCK cells. EBV gp350/220, a replicative cycle glycoprotein added to the virus envelope on egress through the cell membrane, was immunolocalized by confocal microscopy to basolateral cell surfaces only. Apical entry of EBV with subsequent basolateral release of newly replicated virus favors systemic infection by viral dissemination to underlying lymphocytic aggregations. Under conditions of long-term culture, latent EBV was not stably maintained in these cells, suggesting that the epithelial phase of acute EBV infection may be transient.
INTRODUCTION
The late disease manifestations of Epstein-Barr virus (EBV) infection define predominant tissue tropisms of the virus: Burkitt's lymphoma involves B lymphocytes and nasopharyngeal carcinoma is a malignancy of epithelial cell derivation. Mucosal epithelium, the first barrier to viral invasion, must be traversed prior to viral dissemination and intuitively is thought to participate in the initial steps of primary EBV infection. Early events are poorly understood, however, due in part to the inability to procure timely clinical material. Documentation of the initial exposure to virus is difficult since EBV is most frequently transmitted by healthy oropharyngeal shedders of virus. Moreover, acquisition of the virus is generally asymptomatic. Even when primary infection is manifested clinically as infectious mononucleosis, symptoms become apparent only after a 30-to 50-day incubation period, by which time viral dissemination has already taken place throughout the lymphoreticular system (Svedmyr et al., 1984; Diehl et al., 1968) . Thus, studies of acute EBV disease do not provide a full recapitulation of virusepithelial cell interactions that occur during primary infection and highlight the need for epithelial cell models to elucidate EBV pathobiology.
A cardinal property of epithelium unexplored in previous studies of EBV infection (Li et al., 1992 , Knox et al., 1996 Imai et al., 1998 , Fingeroth et al., 1999 is its intrinsic polarity. Asymmetric distribution of proteins and lipids in the plasma membrane, together with the presence of junctional complexes between adjacent cells, creates distinct surface domains, one facing the external environment and the other contacting underlying cells and tissue. Viruses may be restricted in entry to one domain or the other (reviewed in Blau and Compans, 1996) , limiting the sites susceptible to infection. Moreover, the direction of their release can have important implications in pathogenesis (Tashiro et al., 1990a,b) , with basolateral budding providing greater opportunity for systemic spread and interaction with the immune system.
The initial interaction of EBV with B lymphocytes is through contact of the viral attachment protein, gp350/ 220, with cellular CR2 (the type 2 complement receptor; also designated CD21) (Fingeroth et al., 1984) . A complex of three viral glycoproteins, gH, gL, and gp 42, facilitates penetration by binding a coreceptor, HLA class II (Li et al., 1997) . Less is known about entry into epithelium where infection may occur by as yet unidentified receptors (Yoshiyama et al., 1997; Wang et al., 1998; Imai et al., 1998) . However, low levels of CR2 expression sufficient for EBV infection (Fingeroth et al., 1999) have been detected in human epithelial tumor lines (Birkenbach et al., 1992; Billaud et al., 1987) as well as in tongue epithelium (Thomas et al., 1991; Webster-Cyriaque and Raab-Traub, 1998) . Moreover, transfection of the CR2 molecule into numerous cell types confers susceptibility to infection (Ahearn et al., 1988; Li et al., 1992; Knox et al., 1996) . In earlier work using the Madin-Darby canine kidney (MDCK) epithelial cell line, we demonstrated that epithelial cell polarity was a key determinant in the infectious outcome of immunoglobulin A-mediated entry of EBV (Gan et al., 1997) . In this report, using MDCK cells stably transfected with the EBV receptor CR2, we provide evidence for preferential direction of viral entry and release in polarized cells that may elucidate EBV exchange between epithelial cells and lymphocytes at the time of primary infection.
RESULTS

Expression of CR2 in transfected MDCK cells
cDNA encoding the CR2 open reading frame was inserted into a mammalian expression vector, pREP4, that enables the stable transfection of MDCK cells when grown under antibiotic selection. To assess levels of CR2 expression in selected MDCK-pR4CR2 clones, we compared cells containing no vector, the vector alone, or vector plus insert to the control human lymphoid cell lines, Reh and IB4 (Fig. 1) . The anti-CR2 monoclonal antibody (MAb) HB-5 immunoprecipitated the CR2 protein (M r 145,000) from [
35 S]methionine-labeled MDCK-pR4CR2 cells and the lymphoblastoid cell line IB-4, but not from MDCK cells alone, MDCKpR4, or the pre-B cell line Reh that is CR2-negative by virtue of its pre-B stage of differentiation .
Because EBV entry in polarized epithelium may be affected by asymmetric sorting of receptor molecules to a single cell face, we examined CR2 expression on both the apical and the basolateral cell surface domains. Duplicate MDCK-pR4CR2 monolayers grown on glass coverslips were incubated with excess MAb HB5 to saturate receptor sites apically. Bound antibody was then labeled by indirect immunofluorescence staining with Texas red-conjugated reagent. Stained coverslips were treated with either ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA), a chelating agent that disrupts cellular tight junctions, or control buffer. Both cell preparations were reincubated with HB-5 so that CR2 on newly exposed basolateral domains could be visualized with FITC-conjugated secondary antibody. By dual-color immunofluorescence (Fig. 2) , CR2 was evident on both domains in EGTA-treated cells. In mock-treated cultures where tight junctions between cells excluded antibody from basal cell surfaces, apical staining alone was detected. Bipolar expression was confirmed using confluent cell monolayers grown on porous (0.45 m) membrane supports that provided separate access to basolateral or apical cell surfaces by immunologic reagents (result not shown).
In polarized MDCK cells, the ratio of apical to basolateral surface area has been reported to vary from 1:1 to 1:4 on MDCK (strain II) cells (von Bonsdorff et al., 1985; van Genderen et al., 1991) , depending on culture conditions. Disproportionate surface areas between apical and basolateral domains might favor basolateral viral entry, if receptor molecules were otherwise equally distributed. To quantify the amount of CR2 expressed apically as opposed to basolaterally, 125 I-labeled protein A-binding assays were performed on filter-grown monolayers of MDCK-pR4CR2 cells exposed to anti-CR2 MAb HB-5. Results from three separate experiments showed that over 90% of bound antibody was located at the basolateral surface, with the medium counts per minute (cpm) on apical versus basolateral membranes being 126 (range 107-180) and 1350 (range 949-2218), respectively. Even considering disparities in surface area, these results suggest a higher density of CR2 basolaterally that might enhance a basolateral route of entry by EBV.
Efficiency of infection at apical versus basolateral surfaces
To assess polarity of EBV entry, MDCK-pR4CR2 cells were grown on permeable filters and virus was applied to either the apical or the basolateral cell face. Because the basolateral cell surface may be partially occluded by the porous membrane, accessibility to each surface domain was first documented by viral adsorption studies using an excess of radiolabeled Akata virus. When 3 Hlabeled EBV was incubated with the CR2-positive lymphocyte control, Raji, only 27% of the available counts were adsorbed, indicating saturation of natural receptor sites with the virus preparation used (Table 1) . Nonspecific adsorption to receptor-negative Reh lymphocytes was negligible and similar to that occurring with MDCK cells transfected with vector alone. Moreover, comparison of apical versus basolateral counts on the control, CR2-negative MDCK-pR4 cells indicated that there was no undue retention of radiolabeled virus within filter pores (Table 1 ). When labeled virus was applied to each side of filter-grown MDCK-pR4CR2 cells, there was equivalent binding of EBV to both the apical and the basolateral cell surfaces (Table 1) . Interpreted in light of the marked disparity of CR2 distribution between apical and basolateral surfaces, equivalent binding is consistent with partial physical obstruction posed by the culture support membranes as reported previously (Sears et al., 1991; Tugizov et al., 1996) . Nonetheless, for the purpose of quantifying infectivity, these results indicated that comparable amounts of labeled virus were bound to opposing cell surface domains.
Infectivity via each cell face was monitored using indirect immunofluorescence and protein immunoblotting assays for the immediate-early lytic cycle protein, BZLF1 (BamHI Z leftward open reading frame 1). The highly visible nuclear staining obtained with anti-BZLF1 MAb BZ.1 provides a readily quantified marker of infection. In three separate experiments, immunofluorescence staining for BZLF1 24 h postinfection showed significantly more EBV-positive cells in monolayers infected apically than basolaterally (Table 2, Figs. 3A-3C). These findings were corroborated by immunoblot. The 34-to 38-kDa BZLF1 protein was detected in cell monolayers infected apically, whereas only a weak signal was observed in cells infected basolaterally (Fig. 3D) . Thus, despite equal viral binding at both cell surfaces (Table 1) , efficiency of entry as judged by viral antigen expression was greater apically.
One explanation for enhanced infectivity observed apically in MDCK-pR4CR2 cells, despite basolateral predominance of CR2 expression, is the existence of an endogenous coreceptor restricted to the apical membrane. Of note, control cells without transfected CR2 showed barely detectable levels of infection in repeated experiments by immunoblotting (Fig. 3D , MDCK-pR4, lane A) and immunofluorescence staining (not shown). CR2 could not be immunoprecipitated from these caninederived cells with the MAb HB-5 (Fig. 1) . PCR primers specific to human CR2 sequences did not yield a product from MDCK-pR4 cellular DNA (data not shown). However, low-efficiency CR2-independent EBV infection of established human epithelial cell lines, previously deemed resistant, has been convincingly demonstrated by infecting with a viral genome carrying a selective marker (Yoshiyama et al., 1997; Imai et al., 1998) . Using recombinant EBV in which a neomyocin-resistance cassette was inserted into the BDLF3 open reading frame (Borza and Hutt-Fletcher, 1998) , we derived a uniformly infected MDCK-pR4 cell population from apically exposed cells selected in medium containing G418 (data not shown). Together, these results are consistent with the notion of a naturally expressed coreceptor distributed apically that functions synergistically with transfected CR2.
Localization of gp350 to basolateral cell membranes Viral envelope glycoproteins accumulate selectively at the membrane domain from which virus release occurs (Rodriguez-Boulan and Pendergast, 1980; Roth et al., 1983; Owens et al., 1991) and provide a useful correlate for the site of viral egress in polarized cells. EBV, like other herpesviruses, acquires an envelope when passing through the inner nuclear membrane (Torrisi et al., 1989) , but subsequently undergoes what appears to be a process of deenvelopment in the cytoplasm and reenvelopment at the plasma membrane (Gong and Kieff, 1990) . Although little of the EBV glycoprotein gp350/220 is found in the nuclear membrane, its density in the plasma membrane of productively infected lymphocytes is similar to that in enveloped virus itself.
Infected MDCK-pR4CR2 monolayers, when stained simultaneously for BZLF1 and gp350/220, revealed numerous BZLF1-positive cells but with only rare concurrent expression of the late lytic protein gp350/220 (Fig. 4) . The extent to which the transcriptional transactivator BZLF1 drives downstream steps of viral replication is known to vary in lymphocyte culture (Gradoville et al., 1990) , and the discordance seen here between expression of the immediate-early and late replicative proteins is consistent with a largely abortive replicative cycle in this cell system. Indeed, infectious virus was not recovered from culture medium at either cell surface.
However, in a series of optical sections taken horizontally through infected MDCK-pR4CR2 cells by confocal microscopy, we showed circumferential cell staining using anti-gp350-220 MAb 2L10 that appeared only at increasing depths (Figs. 5A-5C ). Cell sections through the vertical axis showed a U-shaped distribution of immunofluorescence delineating the basal cell surface (Fig. 5D ). Both patterns indicated polar accumulation of gp350/220 in basolateral plasma membranes, consistent with basolateral viral egress.
Outcome of infection upon long-term culture
To monitor the state of EBV activation in this cell system over time, we analyzed the configuration of EBV termini (Raab-Traub and Flynn, 1986) as a marker of latent versus replicative infection (Fig. 6) . Essentially all input viral DNA had circularized into the episomal (latent) configuration by 48 h, with one episomal band predominating by 96 h. A gradual diminution in the intensity of the hybridization signal for the EBV episomal band occurred over 4 weeks in culture (Fig. 6A) . To distinguish between episomal loss and mere overgrowth by the noninfected cell population in a mixed culture, single-cell clones were established in which all cells were shown to contain the small nonpolyadenylated virus-encoded RNAs (EBERs), indicating infection with virus (Figs. 6B and 6C). By RT-PCR and protein analyses (data not shown), cloned cells exhibited a type II pattern of latent EBV gene transcription (EBNA1, LMP1, LMP2). Infected cell clones had a population doubling time of 19 h compared to 24 h for the noninfected MDCK-PR4CR2 cell clones when seeded at 8 ϫ 10 3 cells/ml. EBNA1 transcripts could be detected to cell passage 9 in cells diluted 1:10 at each passage. By passage 14, there was no longer PCR evidence for either EBNA1 (responsible for maintenance of the episome) or EBV DNA in infected MDCK-pR4CR2 cells, indicating instability of viral episome maintenance in this epithelial cell system.
DISCUSSION
The bulk of in vitro studies to date that address epithelial cell infection by EBV have focused on patterns of viral gene expression and altered cell growth as a model for EBV oncogenicity in nasopharyngeal carcinoma. Results from our work evaluating infection of polarized epithelium allow predictions regarding the largely uncharted early events in primary EBV infection of humans. First, our findings suggest that initial EBV contact with the epithelial cell barrier is marked by viral entry through the apical cell surface, with release of infectious EBV basolaterally. Such a pattern of viral entry and release, effecting transfer of infectious virus across epithelial boundaries, appears not to be the general rule in polarized epithelium. For example, simian virus 40 and measles virus use the apical cell membrane for both entry and release, whereas Semliki Forest virus and vesicular stomatitis virus transit into and out of cells via the basolateral cell domain (reviewed in Blau and Compans, 1996) . Indications that EBV follows a transepithelial route during acute infection may explain how virus traverses the mucosal epithelial cell barrier to infect underlying lymphoid aggregates without physical breakdown of the epithelial cell sheet.
Since patterned viral entry in polarized cells reflects asymmetric distribution of viral receptors (Fuller et al., 1984; Clayson and Compans, 1988; Rossen et al., 1994) , evidence for enhanced apical infectivity despite the general dispersal of CR2 to all cell surfaces supports the existence of an endogenous EBV coreceptor segregated apically on CR2-transfected MDCK cells. Existence of such a coreceptor may explain the disparate outcomes of IgA-mediated entry by EBV reported in earlier studies using this same cell system (Gan et al., 1997) . Under polarized conditions where the polymeric immunoglobulin receptor (pIgR) is partitioned basolaterally, EBV/IgA immune complexes were transcytosed by pIgR through MDCK cells without evidence for infection. By contrast, in nonpolarized cells where cooperation becomes possible between newly juxtaposed apical and basolateral cell surface molecules, infection occurred (Gan et al., 1997) . Indications of an EBV coreceptor endogenous to MDCK cells is part of accumulating evidence from multiple laboratories for EBV receptors novel to epithelium (Wang et al., 1998; Yoshiyama et al., 1997; Imai et al., 1998) . The findings in MDCK cells raise the possibility that at least some of these receptor molecules are conserved across species.
Finally, the inability of EBV to persist in polarized MDCK cells may reflect the natural progression of acute EBV infection in normal epithelium rather than an artifact of cell culture. The outcome we observed is unlikely to represent mere overgrowth of cultures by cells that have lost viral DNA, given the faster population doubling time of the infected cell clones. Loss of EBV from caninederived MDCK cells is consistent with earlier reports of transient infection produced in human epithelial lines (Li et al., 1992) . Indeed, stable maintenance of latent EBV in vivo has been postulated to require an undifferentiated epithelial cell environment (Knox et al., 1996) atypical of that encountered by virus during primary infection of healthy mucosa. In the normal clinical setting, infection and subsequent clearance of residual virus from oropharyngeal epithelium could occur well within the 4-to 7-week incubation period preceding onset of clinical infectious mononucleosis. In what has been described as a mouse model of infectious mononucleosis induced by the distantly related gammaherpesvirus MHV-68, infection of epithelial cells resolved weeks prior to the onset of the mononucleosis-like phase (Doherty et al., 1997) . Transience of the epithelial phase of acute infection may well explain the variable results reported for epithelial involvement in studies of symptomatic infectious mononucleosis (Lemon et al., 1977; Sixbey et al., 1984; Anagnostopoulos et al., 1995; Karajannis et al., 1997) and is consistent with the prevailing notion that B lymphocytes constitute the major reservoir for persistent EBV infection in the human host.
MATERIALS AND METHODS
Cell lines and virus
Lymphoid cell lines and stock EBV. Controls for expression of cellular or viral proteins were the pre-B-cell line Reh (American Type Culture Collection, Rockville, MD) and Burkitt's lymphoma-derived line BL2 (Calander et al., 1987) , which are EBV-negative; IB4 (King et al., 1980) , Raji (Pulvertaft, 1964) , and Namalwa (Henderson et al., 1983) , which maintain EBV in a latent state; and virus-producing cell lines Akata (Takada et al., 1991) and B95-8 (Miller and Lipman, 1973) . Infectious EBV stock was made from the cell line, Akata, which was induced to replicate virus by treatment with anti-human IgG (Takada and Ono, 1989) . Stock EBV preparations transformed 50% of primary lymphocyte cultures at a dilution of 10 Ϫ4 in the lymphocyte transformation assay (Moss and Pope, 1972) . Recombinant Akata virus bearing the neomycin-resistant cassette (gift of L. Hutt-Fletcher, University of Missouri at Kansas City; Borza and Hutt-Fletcher, 1998 ) was produced as above for use in a single experiment.
Epithelial line MDCK-pR4CR2. cDNA encoding the intact CR2 open reading frame (Li et al., 1992 ; gift of M. Birkenbach, University of Chicago) was inserted by blunt ligation into pREP4 (Invitrogen, Carlsbad, CA), an episomal mammalian expression vector containing the EBV origin of plasmid replication, the EBNA-1 coding region to allow high-copy replication, the RSV LTR promoter, and a hygromycin-selection marker. Constructs pREP4-CR2 or pREP4 alone were transfected into MDCK cells, strain II (low resistance, 100 to 300 ⍀/cm 2 ) (gift of R. Owens, St. Jude Children's Research Hospital) using Lipofectamine (Gibco BRL, Life Technologies Inc., Gaithersburg, MD) as per the manufacturer's instructions. Transfected cells were selected on hygromycin B (Calbiochem-Novabiochem Corp., La Jolla, CA) and, after 4 weeks in culture, single-cell clones were established. Cell clones expressing high levels of CR2 were selected for further experimentation. CR2 expression in MDCKpR4CR2 cells, relative to lymphoid cells, was shown by metabolically labeling cultures with [
35 S]methionine (200 Ci/ml, ICN, Costa Mesa, CA). Cells were lysed with detergent, and protein lysates were quantified (Bio-Rad Protein Assay, Bio-Rad, Richmond, CA) and then immunoprecipitated with purified anti-CR2 antibody HB-5 (Tedder et al., 1984) . Radiolabeled proteins were separated on denaturing 10% polyacrylamide gels containing sodium dodecyl sulfate (SDS), and the proteins were detected by autoradiography of the dried slab gels.
Polarized epithelial growth and receptor expression
MDCK-pR4CR2 cells were cultured on permeable membranes (pore size, 0.45 m) in microwell chambers (Transwells; Costar, Cambridge, MA) in minimum essential medium with 10% bovine serum. After 96 h in culture, the integrity of each monolayer was ascertained by measuring transmembrane electrical resistance (TER) with a Millicell-ERS meter (Millipore Corp., Bedford, MA) . MDCK epithelial cultures selected for experiments were required to have a TER of greater than 100 ⍀/cm 2 , a measurement equated with monolayer impermeability to the macromolecule inulin and the polarized expression of cellular proteins (Gan et al., 1997) .
To localize CR2 expression to particular cell surface domains, MAb HB-5 was applied selectively either to the apical surface of cells or to their basolateral membranes made accessible by growth on porous cell supports. Bound antibody was detected by standard indirect im-munofluorescence staining with fluorescein isothiocyanate-conjugated (FITC) goat anti-mouse immunoglobulin (Ig) G (Southern Biotechnologies, Birmingham, AL). Alternatively, bound HB-5 was quantified by application of rabbit anti-mouse IgG (Southern Biotechnology) followed by 1 ϫ 10 5 cpm 125 I-labeled protein A (1.85 MBq 50 Ci, Amersham Life Sciences, Buckinghamshire, UK). Filters were washed three times with phosphate-buffered saline and the amount of radioactivity was determined in a Beckman scintillation counter (Beckman, Irvine, CA). Levels of nonspecific binding of 125 I-labeled protein A were determined using MDCK-pR4 cells processed as above, and these background counts were subtracted from experimental readings obtained with MDCK-pR4CR2. Values in each experiment represent the mean from triplicate filters. A third approach utilized dual immunofluorescence on live cells grown to confluence on glass coverslips, incubated at 4°C with the primary MAb HB-5, and then incubated with Texas red-conjugated goat antimouse IgG (Southern Biotechnology). Stained intact and EGTA (Sigma, St. Louis, MO)-disrupted monolayers (Owens and Compans, 1989) were fixed in 3% paraformaldehyde and reincubated with HB-5. After being washed, EGTA-and mock-treated cells were incubated with FITC-labeled goat anti-mouse IgG. Simultaneous dual fluorescence was visualized using an Olympus BH-2 microscope equipped with an Omega triple-dye filter set (Olympus Corp., Lake Success, NY).
Virus binding and MDCK cell infection
3 H-labeled EBV (gift of L. Hutt-Fletcher, University of Missouri at Kansas City) was prepared from Akata cells as previously described (Takada and Ono, 1989; Sixbey et al., 1987) . Trichloracetic acid precipitation of labeled stock virus yielded 7173 cpm incorporated out of a total of 23, 135 cpm for the same volume of unprecipitated virus stock. For viral binding studies, confluent monolayers of MDCK-pR4CR2 or MDCK-pR4 cells were rinsed in ice-cold phosphate-buffered saline.
3 H-labeled EBV was adsorbed to the apical or basolateral surface of culture membranes in the presence of 100 g unlabeled thymidine and then overlaid with cold medium at 4°C for 3 h to maximize binding. CR2-positive (Raji) and -negative (Reh) lymphocyte cultures were similarly processed but as cell pellets. Cells were thoroughly rinsed with cold PBS to remove excess virus, and bound virus was quantified by total counts retained. For infection studies, unlabeled virus was bound as above and warm medium was subsequently added to both sides of the filter for incubation at 37°C.
Immunofluorescence and immunoblotting for viral antigens
Cells were fixed in acetone and examined for EBV protein expression by standard indirect immunofluorescence techniques described above. MAb BZ.1, specific for the immediate-early protein BZLF1 (gift of L. S. Young, University of Birmingham, UK; Young et al., 1991) , was used as primary antibody. For immunolocalization of EBV protein in polarized epithelium, MDCK-pR4CR2 cells infected apically were fixed 72-96 h postinfection with 4% paraformaldehyde for 30 min and then permeabilized with 1% Triton 100 for 5 min. Anti-gp350/220 MAb 2L10 (Tanner et al., 1987) was added to both membrane surfaces for a 1-h incubation, washed with phosphate-buffered saline, and then stained with FITC-labeled goat anti-mouse IgG. For double-staining, MAb BZ.1 was first applied followed by Texas red-conjugated goat antimouse IgG. Confocal imaging was performed on a BioRad MRC 10W4 Laser Sharp system (Bio-Rad, Hercules, CA) equipped with an Olympus Bx50 microscope with a 60X objective. Optical sections at a thickness of 0.7 m were collected through the samples, stored in memory, and used individually or after 3-dimensional reconstruction.
For immunoblotting, cells were lysed in SDS-PAGE sample buffer containing 10% ␤-mercaptoethanol. Samples were sonicated, electrophoresed on 7.5% SDS-polyacrylamide gels, and transferred to polyvinylidene fluoride membranes (Millipore, Bedford MA) using a semidry electroblotter (Bio-Rad, Richmond, CA). To detect BZLF1, blots were incubated with BZ.1 at a 1:1000 dilution and antibody binding was detected by chemiluminescence per the manufacturer's protocol (Rad-Free kit; Schleicher & Schuell, Keene, NH).
EBV nucleic acid hybridization and PCR analyses
The molecular configuration of EBV termini (linear or episomal) was determined using a 32 P-labeled BamHI NJhet fragment of EBV DNA that spans the terminal repeats (Raab-Traub and Flynn, 1986) . Total cellular DNA from infected MDCK-pR4CR2 cells was digested with BamHI restriction endonuclease, loaded at 10 g of DNA per well, separated by electrophoresis in a 0.8% agarose gel, and then transferred to nylon membranes for hybridization. EBV status of single-cell clones of infected MDCK-pR4CR2 cells was determined by in situ cytohybridization using digoxigeninlabeled riboprobes specific for EBER1 (MacMahon et al., 1991) . Bound probe was detected by an anti-digoxigenin antibody-alkaline phosphatase conjugate (Boehringer Mannheim, Mannheim, Germany) as per the manufacturer's protocol. PCR primer sequences and RT-PCR analysis for EBNA1 and LMP2 were as described elsewhere (Brooks et al., 1992) . PCR primers for CR2 DNA were 5Ј-ATTGCTGGACAGGGAGT-TGC-3Ј and 5Ј-CACAGACTGGTGCAGATGGC-3Ј (5Ј base coordinates 841 and 1268, respectively; Fujisaku et al., 1989) . PCR amplification was performed as previously described (Gan et al., 1997) .
